MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00464-023-10212-9

Медицинская библиотека · Surgical endoscopy · 2023

Surgeon experience with insurance barriers to offering gastric bypass as an evidence-based operation for pathologic GERD.

Ibele Anna R, Nau Peter N, Galvani Carlos, Roth J Scott, Goldberg Ross F, Kurian Marina S, Khaitan Leena, Gould Jon, Pandya Yagnik K, SAGES Foregut Taskforce

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Obesity is an increasingly prevalent public health problem often associated with poorly controlled gastroesophageal reflux disease. Fundoplication has been shown to have limited long-term efficacy in patients with morbid obesity and does not address additional weight-related co-morbidities. Roux-en-Y gastric bypass (RYGB) is the gold standard operation for durable resolution of GERD in patients with obesity, and is also used as a salvage operation for GERD after prior foregut surgery. Surgeons report access to RYGB as surgical treatment for GERD is often limited by RYGB-specific benefit exclusions embedded within insurance policies, but the magnitude and scope of this problem is unknown.

METHODS

A 9-item survey evaluating surgeon practice and experience with insurance coverage for RYGB for GERD was developed and piloted by a SAGES Foregut Taskforce working group. This survey was then administered to surgeon members of the SAGES Foregut Taskforce and to surgeons participating in the SAGES Bariatrics and/or Foregut Facebook groups.

RESULTS

187 surgeons completed the survey. 89% reported using the RYGB as an anti-reflux procedure. 44% and 26% used a BMI of 35 kg/m2 and 30 kg/m2 respectively as cutoff for the RYGB. 89% viewed RYGB as the procedure of choice for GERD after bariatric surgery. 69% reported using RYGB to address recurrent reflux secondary to failed fundoplication. 74% of responders experienced trouble with insurance coverage at least half the time RYGB was offered for GERD, and 8% reported they were never able to get approval for RYGB for GERD indications in their patient populations.

CONCLUSION

For many patients, GERD and obesity are related diseases that are best addressed with RYGB. However, insurance coverage for RYGB for GERD is often limited by policies which run contrary to evidence-based medicine. Advocacy is critical to improve access to appropriate surgical care for GERD in patients with obesity.

Для цитирования: Ibele Anna R, Nau Peter N, Galvani Carlos, Roth J Scott, Goldberg Ross F, Kurian Marina S, Khaitan Leena, Gould Jon, Pandya Yagnik K, SAGES Foregut Taskforce. Surgeon experience with insurance barriers to offering gastric bypass as an evidence-based operation for pathologic GERD.. Surgical endoscopy. 2023. DOI: 10.1007/s00464-023-10212-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.